Capsugel expands manufacturing capacity at three FDF plants

By Zachary Brennan contact

- Last updated on GMT

Three Capsugel plants have seen recent expansions
Three Capsugel plants have seen recent expansions

Related tags: Dose

Capsugel’s DFS Unit has upgraded three FDF (finished dose form) manufacturing facilities in the US and Europe.

The expansions come in response to growing customer demand for hormonal and high-potent compounds for soft gelatin and liquid-fill hard capsules. 

At its Ploermel plant in France, Capsugel increased containment capacity to deal with hormonal and high potent compounds in soft gel manufacturing. The expansion also includes a new dosing system and high-speed capsule printing cabaility. 

The company also added more lab space, equipment and analytical scientists at its facility in Livingston, UK. A CFS 1500 capsule filling and sealing machine was installed at the plant and incorporated into the team’s finished dosage form development process. 

Meanwhile, in the US, at the company’s Greenwood, North Carolina-based plant, Capsugel commissioned and validated a new commercial scale liquid-fill encapsulation unit for pharmaceutical applications. 

Another installation at the site is for a commercial production capability for the new solid lipid pellet (SLP) technology. SLP technology is currently being used on select customer development projects as a unique lipid-based formulation option for bioenhancement and other formulation issues. 

Anthony Macci, SVP of Global Operations, told In-Pharmatechnologist that the company expects to “add manufacturing, quality assurance and support staff as these new products are introduced​.” 

Each of our manufacturing facilities provides unique and complementary solutions and offerings that will significantly impact Capsugel’s DFS business unit​,” he added. 

Summer of Acquisitions​ 

The expansions cap a busy summer for Capsugel in terms of acquisitions and expansions. Earlier this month Capsugel bought Bend Research​ to expand its dosage form solutions. 

That acquisition also followed the purchase of Encaps​ in March. The Livingston, UK plant was acquired as part of that deal. Earlier this summer the company also launched a new encapsulating platform​. 

The company’s DFS (Dosage Formulation Unit) was established in February and is based in Morristown, New Jersey.

Related news

Show more

Related products

show more

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers

Follow us


View more